GUARDANT HEALTH INC (GH) Stock Fundamental Analysis

NASDAQ:GH • US40131M1099

103.1 USD
-3.28 (-3.08%)
At close: Feb 20, 2026
103.1 USD
0 (0%)
After Hours: 2/20/2026, 8:00:01 PM
Fundamental Rating

2

GH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. While GH seems to be doing ok healthwise, there are quite some concerns on its profitability. GH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • GH had negative earnings in the past year.
  • In the past year GH has reported a negative cash flow from operations.
  • GH had negative earnings in each of the past 5 years.
  • GH had a negative operating cash flow in each of the past 5 years.
GH Yearly Net Income VS EBIT VS OCF VS FCFGH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200M -400M -600M

1.2 Ratios

  • GH has a Return On Assets of -31.23%. This is amonst the worse of the industry: GH underperforms 84.31% of its industry peers.
Industry RankSector Rank
ROA -31.23%
ROE N/A
ROIC N/A
ROA(3y)-32.29%
ROA(5y)-25.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GH Yearly ROA, ROE, ROICGH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • GH has a Gross Margin of 63.76%. This is amongst the best in the industry. GH outperforms 84.31% of its industry peers.
  • In the last couple of years the Gross Margin of GH has declined.
  • The Profit Margin and Operating Margin are not available for GH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.32%
GM growth 5Y-1.93%
GH Yearly Profit, Operating, Gross MarginsGH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

4

2. Health

2.1 Basic Checks

  • GH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for GH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GH Yearly Shares OutstandingGH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
GH Yearly Total Debt VS Total AssetsGH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.02 indicates that GH is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.02, GH is in line with its industry, outperforming 49.02% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 2.02
ROIC/WACCN/A
WACC8.37%
GH Yearly LT Debt VS Equity VS FCFGH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 3.50 indicates that GH has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 3.50, GH belongs to the best of the industry, outperforming 86.27% of the companies in the same industry.
  • GH has a Quick Ratio of 3.12. This indicates that GH is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.12, GH belongs to the best of the industry, outperforming 84.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.5
Quick Ratio 3.12
GH Yearly Current Assets VS Current LiabilitesGH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 19.66% over the past year.
EPS 1Y (TTM)19.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%39.37%

3.2 Future

  • Based on estimates for the next years, GH will show a very strong growth in Earnings Per Share. The EPS will grow by 29.93% on average per year.
  • GH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.20% yearly.
EPS Next Y12.33%
EPS Next 2Y20.18%
EPS Next 3Y31.07%
EPS Next 5Y29.93%
Revenue Next Year27.42%
Revenue Next 2Y27.56%
Revenue Next 3Y26.63%
Revenue Next 5Y26.2%

3.3 Evolution

GH Yearly Revenue VS EstimatesGH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B
GH Yearly EPS VS EstimatesGH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5

1

4. Valuation

4.1 Price/Earnings Ratio

  • GH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GH Price Earnings VS Forward Price EarningsGH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GH Per share dataGH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GH's earnings are expected to grow with 31.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.18%
EPS Next 3Y31.07%

0

5. Dividend

5.1 Amount

  • GH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

GUARDANT HEALTH INC

NASDAQ:GH (2/20/2026, 8:00:01 PM)

After market: 103.1 0 (0%)

103.1

-3.28 (-3.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-19
Earnings (Next)04-28
Inst Owners97.26%
Inst Owner Change1.95%
Ins Owners4.04%
Ins Owner Change-1.71%
Market Cap13.28B
Revenue(TTM)N/A
Net Income(TTM)-398.79M
Analysts85.63
Price Target123.26 (19.55%)
Short Float %7.67%
Short Ratio4.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.57%
Min EPS beat(2)-2.26%
Max EPS beat(2)-0.89%
EPS beat(4)0
Avg EPS beat(4)-5.38%
Min EPS beat(4)-18.05%
Max EPS beat(4)-0.34%
EPS beat(8)1
Avg EPS beat(8)-3.14%
EPS beat(12)5
Avg EPS beat(12)4.15%
EPS beat(16)7
Avg EPS beat(16)3.82%
Revenue beat(2)2
Avg Revenue beat(2)7.96%
Min Revenue beat(2)6.68%
Max Revenue beat(2)9.24%
Revenue beat(4)4
Avg Revenue beat(4)5.45%
Min Revenue beat(4)1.97%
Max Revenue beat(4)9.24%
Revenue beat(8)8
Avg Revenue beat(8)5.72%
Revenue beat(12)11
Avg Revenue beat(12)4.58%
Revenue beat(16)13
Avg Revenue beat(16)3.54%
PT rev (1m)12.92%
PT rev (3m)77.92%
EPS NQ rev (1m)-0.38%
EPS NQ rev (3m)10.8%
EPS NY rev (1m)17.86%
EPS NY rev (3m)32.58%
Revenue NQ rev (1m)0.77%
Revenue NQ rev (3m)1.31%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)0.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.72
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.86
EYN/A
EPS(NY)-2.51
Fwd EYN/A
FCF(TTM)-2.04
FCFYN/A
OCF(TTM)-1.73
OCFYN/A
SpS7.01
BVpS-2.75
TBVpS-2.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.76%
FCFM N/A
ROA(3y)-32.29%
ROA(5y)-25.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.32%
GM growth 5Y-1.93%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.99%
Cap/Sales 4.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.5
Quick Ratio 3.12
Altman-Z 2.02
F-Score5
WACC8.37%
ROIC/WACCN/A
Cap/Depr(3y)115.32%
Cap/Depr(5y)203.86%
Cap/Sales(3y)8.54%
Cap/Sales(5y)12.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.44%
EPS Next Y12.33%
EPS Next 2Y20.18%
EPS Next 3Y31.07%
EPS Next 5Y29.93%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%39.37%
Revenue Next Year27.42%
Revenue Next 2Y27.56%
Revenue Next 3Y26.63%
Revenue Next 5Y26.2%
EBIT growth 1Y14.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.43%
EBIT Next 3Y25.17%
EBIT Next 5Y22.91%
FCF growth 1Y27.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.86%
OCF growth 3YN/A
OCF growth 5YN/A

GUARDANT HEALTH INC / GH FAQ

What is the ChartMill fundamental rating of GUARDANT HEALTH INC (GH) stock?

ChartMill assigns a fundamental rating of 2 / 10 to GH.


What is the valuation status for GH stock?

ChartMill assigns a valuation rating of 1 / 10 to GUARDANT HEALTH INC (GH). This can be considered as Overvalued.


What is the profitability of GH stock?

GUARDANT HEALTH INC (GH) has a profitability rating of 1 / 10.


Can you provide the financial health for GH stock?

The financial health rating of GUARDANT HEALTH INC (GH) is 4 / 10.